Here, we measured the extent of positive and negative changes in the checkpoint proteins in response to BCG therapy, intending to generate a hypothesis that connects BCG with a possible mechanism that may prevent AD via PD-1/PD-L1 interaction. The gene discussed is CD274; the disease is Alzheimer disease.